• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zomedica Pharmaceuticals Corp (NY: ZOM )

    0.1204 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Zomedica Pharmaceuticals Corp

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    ZOM Stock Is on the Move, but That Doesn’t Make It a Good Play Here
    After months of declining, ZOM stock may have found a floor. The question is if that will hold. Set this one aside for the time being. 
    Via InvestorPlace
    63 Biggest Movers From Yesterday
    Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
    Via Benzinga
    Zomedica's Stock Approaches Important Level
    Shares of Zomedica Corp. (NYSE: ZOM) are trading higher after the company released earnings. If the stock continues to rally, there's a chance it runs into sellers around... 
    Via Benzinga
    45 Stocks Moving In Thursday's Mid-Day Session
    Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,... 
    Via Benzinga
    Why Zomedica Stock Is Zooming Higher Today
    Investors appear to be bullish about the stock after a major investment bank disclosed earlier this week that it had bought shares of Zomedica. 
    Via The Motley Fool
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    ZOM Stock: What Investors Are Saying About Meme Stock Favorite Zomedica as Shares Fly
    Zomedica (ZOM) stock is soaring higher on Thursday as the stock continues a rally that's been taking place over the last couple of days. 
    Via InvestorPlace
    22 Stocks Moving in Thursday's Pre-Market Session
    Gainers Good Works Acquisition Corp. (NASDAQ: GWAC) rose 29.8% to $13.01 in pre-market trading. Good Works Acquisition and Cipher Mining reported shareholder approval of business... 
    Via Benzinga
    1 Number That Might Send Investors Running From Zomedica's Stock
    A lack of sales growth and rising expenses could send this struggling stock even lower. 
    Via The Motley Fool
    ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?
    Today, investors in Zomedica are seeing a lot of green as a recent meme-stock surge takes ZOM stock materially higher. 
    Via InvestorPlace
    The Second Half of 2021 Should Be Much Easier for Zomedica Investors
    So far, it hasn't been easy to stay the course with ZOM stock. Q3 and Q4 developments, however, should lift the shareholders' spirits. 
    Via InvestorPlace
    Why Zomedica Stock Has Lost Its Luster
    There are a few glaring reasons behind the once high-flying stock's decline. 
    Via The Motley Fool
    77 Biggest Movers From Yesterday
    Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
    Via Benzinga
    54 Stocks Moving In Thursday's Mid-Day Session
    Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency... 
    Via Benzinga
    What's Happening With Zomedica's Stock Today?
    Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.6% at $0.49 Thursday morning after the company reported second-quarter earnings results. Zomedica reported... 
    Via Benzinga
    30 Stocks Moving in Thursday's Pre-Market Session
    Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ... 
    Via Benzinga
    Zomedica Is an Excellent Spec Play After Falling
    ZOM stock is trading at a discount, which means this is the perfect time for investors to trade this one for short-term profits. 
    Via InvestorPlace
    Time Is Passing Too Slowly For Zomedica Speculators
    Zomedica speculators are being told to be patient, but there's a time cost to money and some will likely let ZOM stock go soon. 
    Via InvestorPlace
    There’s Little That’s Attractive About Once-Hot Zomedica Stock… for Now
    Zomedica has become a slow-motion train wreck. ZOM stock investors should look for alternatives to the animal diagnostics firm. 
    Via InvestorPlace
    Zomedica Stock Might Not Appeal To Millennials as Much as Some Hope
    While young people own pets, the question for ZOM stock is whether they will truly care for them. 
    Via InvestorPlace
    Avoid Zomedica Stock As It’s Bogged Down By Too Many Red Flags
    Resignation of Zomedica's President and CMO, and the CEO are red flags. Wait to buy ZOM stock until 30 cents for a margin of safety. 
    Via InvestorPlace
    Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait?
    Zomedica came public too soon, but it does have enough cash to see a finish line. The question is, can ZOM stock investors afford to wait? 
    Via InvestorPlace
    Ignore Zomedica’s Recent Struggles. The Road Ahead Remains Bright.
    ZOM stock has come under price pressure recently, but the outlook is bright as Zomedica plots a road map to success. 
    Via InvestorPlace
    Speculative Investors Are Crazy Not to Buy Zomedica at Its Current Prices
    Under 75 cents, ZOM stock is a penny stock worth betting on 
    Via InvestorPlace
    Wait for Zomedica to Give Up More of its Meme Stock Gains
    It's not there yet, but if ZOM stock pulls back another 50% or so, the risk/return proposition will be more in your favor. 
    Via InvestorPlace
    Zomedica Stock Still Has a Rocky Few Months Left Ahead of It
    ZOM stock is rife with massive potential. But it's the same potential that has gone unfulfilled for the past few months. 
    Via InvestorPlace
    A Little Patience Could Go a Long Way For ZOM Stock
    Now that Truforma is in the market, it’s time for investors to see revenue growth 
    Via InvestorPlace
    2 Risky Meme Stocks You Don't Want to Hold With 'Diamond Hands'
    Some stocks you can buy and forget. With Zomedica and ContextLogic, you'll want to keep a much closer eye on matters. 
    Via The Motley Fool
    Wait for the Reddit Set to Sell Before Buying Bionano Stock
    Genomics play BNGO stock may pay off down the road, but wait for a meme stock investor exodus before making it a buy 
    Via InvestorPlace
    Zomedica Is Way Undervalued Here as Its Gear Is Catching On
    InvestorPlace’s Mark Hake estimates Zomedica is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy. Here’s why I agree. 
    Via InvestorPlace
    Radio Silence May Indicate a Problem for Zomedica Stock
    Zomedica is due to report results for the current quarter on Aug. 11. Until then, investors have nothing with which to weigh ZOM stock. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.